Navigation Links
Alarming growth in expected CO2 emissions in China, finds UC analysis
Date:3/10/2008

eir findings upon pollution data from China's 30 provincial entities.

Auffhammer said this paper should serve as an alarm challenging the widely held belief that actions taken by the wealthy, industrialized nations alone represent a viable strategy towards the goal of stabilizing atmospheric concentrations of carbon dioxide.

"Making China and other developing countries an integral part of any future climate agreement is now even more important," said Auffhammer. "It had been expected that the efficiency of China's power generation would continue to improve as per capita income increased, slowing down the rate of CO2 emissions growth. What we're finding instead is that the emissions growth rate is surpassing our worst expectations, and that means the goal of stabilizing atmospheric CO2 is going to be much, much harder to achieve."

Researchers traditionally calculate the CO2 emissions for a region or country from data on fossil fuel consumption. Existing models then use those emission figures and factor in such variables as population size, a society's affluence and technology developments to forecast the growth of greenhouse gas emissions.

In explaining the startling differences in results from previous estimates for China's carbon emissions growth, the UC researchers point out that they used province-level figures in their analysis to obtain a more detailed picture of the country's CO2 emissions up to 2004.

"Everybody had been treating China as single country, but each of the country's provinces is larger than many European countries, both in geographic size and population," said Carson. "In addition, there is a wide range in economic development and wealth from one province to the next, as well as major differences in population growth, all of which has an effect on energy consumption that cannot be easily addressed in models based upon aggregate national data."

Since data on fossil fuel consumption is not repor
'/>"/>

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
2. Nitrogen pollution boosts plant growth in tropics by 20 percent
3. New treatment boosts bone healing and regrowth
4. Gene dose affects tumor growth
5. Researchers discover protein that controls bone growth
6. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
7. RNA interference therapy heals growth deficiency disorder in a live animal
8. Predicting growth hormone treatment success
9. New studies suggest brain overgrowth in 1-year-olds linked to development of autism
10. Mechanism for regulation of growth and differentiation of adult muscle stem cells is revealed
11. EMD Serono launches easypod, new electronic growth hormone injection device
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology Technology:RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 2RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 3RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 4RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 5RE-COVER Study Evaluating Dabigatran Etexilate Met Primary Outcome for the Six-Month Treatment of Patients with Acute Venous Thromboembolism (VTE) 6BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2